For example, women carrying highly penetrant mutations in the BRCA1 and BRCA2 genes have an elevated risk of developing breast (BRCA1/2 carriers, 36–90%) and ovarian cancer (BRCA1 carriers, 24–59%; BRCA2 carriers, 8–35%) [25,26]. The gene discussed is BRCA2; the disease is ovarian carcinoma.